- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
-
Is IBB the Best Biotech ETF?
-
Playing Health Care Reform with Biotech ETFs IBB and XBI
-
Biotech ETFs: A Better Way to Go
-
Fast Money Recap: Mister Softee No More? (6/16/09)
-
Can Obama’s Reform Proposals Reignite Biotech and Health Care ETFs?
-
Exploring Biotech ETFs
-
Seven ETF Momentum Gainers and Losers
-
Stem Cell Index Surges in Past Week
-
Obama’s First 100 Days: Sector ETF Winners and Losers
-
ETF Momentum Gainers and Losers: Week of 4/20/09
-
Does More Cash and Less Debt Equal Stock Market Gains?
-
Equity ETFs with the Smallest Bounce
-
Banking on NeoStem
-
Today's Data: Are Economists Too Bearish?
-
Congress Ponders AIG While SEC Mulls Uptick
-
Biotech Dip: Sector Weakness, or Buying Opportunity?
-
With Funding Ban Lifted, Stem Cell Index Soars
-
How Obama's Healthcare Reform Could Affect Biotech ETFs
-
Three Noteworthy Sectors: Gold, Food and Healthcare
-
Expecting Post-Stimulus Catalyst for Stem Cell Research Companies
-
Biotechnology: The New Defensive Sector That's Set to Rise?
-
The State of Financial Markets and U.S. Dollar in 2009, Part II
-
The State of Financial Markets and U.S. Dollar in 2009, Part I
-
Fast Money Recap - The Bad Bank Is Coming (1/27/09)
-
Fast Money Recap - Much Ado about Yahoo (1/26/09)
-
Utilities and Biotech ETFs: Shining Stars During Terrible Trading Days
-
Trading Updates on Biotech, ETFs, Google and Apple
-
Fast Money Recap - HSBC Is Falling off a Cliff (1/12/09)
-
Bio-Pharma, Diagnostics Buyout Binge Begins
-
Taking Advantage of Biotech Sector with ETFs
-
Biotech ETFs a Rare Safe Haven
-
What Companies Will Benefit from Obama's Vision?
-
Healthcare ETFs Are Outpacing the Market
-
Regional Banking ETF: 3rd Best Year Over Year Stock Performer?
-
'When There's Blood in the Streets', Buy Biotech Stocks
-
Biotech ETFs Hold Their Own During Crisis
-
Obama or McCain: Who’s Better for Healthcare Investors?
-
Biotech ETFs: Can You Handle 209% Volatility?
-
Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare
-
Inverse, Healthcare ETFs Raise the Roof in July
-
Eleven Large Volume Increase ETFs to Examine